{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:37:47Z","timestamp":1790739467310,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,8]],"date-time":"2021-04-08T00:00:00Z","timestamp":1617840000000},"content-version":"vor","delay-in-days":372,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013302","name":"King Abdullah International Medical Research Center","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100013302","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.ymthe.2020.01.027","type":"journal-article","created":{"date-parts":[[2020,2,4]],"date-time":"2020-02-04T19:24:06Z","timestamp":1580844246000},"page":"1043-1055","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Type 1 Interferon Responses Underlie Tumor-Selective Replication of Oncolytic Measles Virus"],"prefix":"10.1016","volume":"28","author":[{"given":"Sarah","family":"Aref","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Z.","family":"Castleton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharine","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Burt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditi","family":"Dey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Leongamornlert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel J.","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina","family":"Okasha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adele K.","family":"Fielding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2020.01.027_bib1","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1586\/14737140.8.10.1581","article-title":"Oncolytic viruses: a novel form of immunotherapy","volume":"8","author":"Prestwich","year":"2008","journal-title":"Expert Rev. Anticancer Ther."},{"key":"10.1016\/j.ymthe.2020.01.027_bib2","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2174\/1568009617666170222125035","article-title":"Clinical trials with oncolytic measles virus: current status and future prospects","volume":"18","author":"Msaouel","year":"2018","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.ymthe.2020.01.027_bib3","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1038\/nrmicro1550","article-title":"Global measles elimination","volume":"4","author":"Moss","year":"2006","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ymthe.2020.01.027_bib4","doi-asserted-by":"crossref","first-page":"6025","DOI":"10.1128\/jvi.67.10.6025-6032.1993","article-title":"Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus","volume":"67","author":"Naniche","year":"1993","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2020.01.027_bib5","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0092-8674(93)80071-L","article-title":"The human CD46 molecule is a receptor for measles virus (Edmonston strain)","volume":"75","author":"D\u00f6rig","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2020.01.027_bib6","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/35022579","article-title":"SLAM (CDw150) is a cellular receptor for measles virus","volume":"406","author":"Tatsuo","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2020.01.027_bib7","doi-asserted-by":"crossref","first-page":"e1002240","DOI":"10.1371\/journal.ppat.1002240","article-title":"Tumor cell marker PVRL4 (nectin 4) is an epithelial cell receptor for measles virus","volume":"7","author":"Noyce","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ymthe.2020.01.027_bib8","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/nature10639","article-title":"Adherens junction protein nectin-4 is the epithelial receptor for measles virus","volume":"480","author":"M\u00fchlebach","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2020.01.027_bib9","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nsmb.1967","article-title":"The heads of the measles virus attachment protein move to transmit the fusion-triggering signal","volume":"18","author":"Navaratnarajah","year":"2011","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.ymthe.2020.01.027_bib10","doi-asserted-by":"crossref","first-page":"4919","DOI":"10.1158\/0008-5472.CAN-04-0884","article-title":"High CD46 receptor density determines preferential killing of tumor cells by oncolytic measles virus","volume":"64","author":"Anderson","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.ymthe.2020.01.027_bib11","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1038\/mt.2013.171","article-title":"Measles virus entry through the signaling lymphocyte activation molecule governs efficacy of mantle cell lymphoma radiovirotherapy","volume":"21","author":"Miest","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2020.01.027_bib12","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/77558","article-title":"Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus","volume":"6","author":"Stojdl","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.ymthe.2020.01.027_bib13","doi-asserted-by":"crossref","first-page":"e279","DOI":"10.1371\/journal.pone.0000279","article-title":"Cytosolic 5\u2032-triphosphate ended viral leader transcript of measles virus as activator of the RIG I-mediated interferon response","volume":"2","author":"Plumet","year":"2007","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ymthe.2020.01.027_bib14","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1128\/JVI.01690-09","article-title":"Both RIG-I and MDA5 RNA helicases contribute to the induction of alpha\/beta interferon in measles virus-infected human cells","volume":"84","author":"Ikegame","year":"2010","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2020.01.027_bib15","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1016\/j.micinf.2006.04.005","article-title":"The interferon-inducible RNA helicase, mda-5, is involved in measles virus-induced expression of antiviral cytokines","volume":"8","author":"Bergh\u00e4ll","year":"2006","journal-title":"Microbes Infect."},{"key":"10.1016\/j.ymthe.2020.01.027_bib16","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.coviro.2011.10.008","article-title":"Interferon-stimulated genes and their antiviral effector functions","volume":"1","author":"Schoggins","year":"2011","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.ymthe.2020.01.027_bib17","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1146\/annurev-immunol-032713-120231","article-title":"Interferon-stimulated genes: a complex web of host defenses","volume":"32","author":"Schneider","year":"2014","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.ymthe.2020.01.027_bib18","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1093\/jnci\/djy033","article-title":"Constitutive interferon pathway activation in tumors as an efficacy determinant following oncolytic virotherapy","volume":"110","author":"Kurokawa","year":"2018","journal-title":"J.\u00a0Natl. Cancer Inst."},{"key":"10.1016\/j.ymthe.2020.01.027_bib19","doi-asserted-by":"crossref","first-page":"6223","DOI":"10.1073\/pnas.0700690104","article-title":"Transformation of human mesenchymal stem cells increases their dependency on oxidative phosphorylation for energy production","volume":"104","author":"Funes","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2020.01.027_bib20","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/gb-2003-4-9-117","article-title":"Comparing protein abundance and mRNA expression levels on a genomic scale","volume":"4","author":"Greenbaum","year":"2003","journal-title":"Genome Biol."},{"key":"10.1016\/j.ymthe.2020.01.027_bib21","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.cell.2016.03.014","article-title":"On the dependency of cellular protein levels on mRNA abundance","volume":"165","author":"Liu","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2020.01.027_bib22","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1128\/JVI.02106-12","article-title":"Innate immune defense defines susceptibility of sarcoma cells to measles vaccine virus-based oncolysis","volume":"87","author":"Berchtold","year":"2013","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2020.01.027_bib23","doi-asserted-by":"crossref","first-page":"44892","DOI":"10.18632\/oncotarget.6285","article-title":"Sensitivity of human pleural mesothelioma to oncolytic measles virus depends on defects of the type I interferon response","volume":"6","author":"Achard","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.ymthe.2020.01.027_bib24","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nri2314","article-title":"Interferon-inducible antiviral effectors","volume":"8","author":"Sadler","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ymthe.2020.01.027_bib25","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.virusres.2019.01.014","article-title":"A key anti-viral protein, RSAD2\/VIPERIN, restricts the release of measles virus from infected cells","volume":"263","author":"Kurokawa","year":"2019","journal-title":"Virus Res."},{"key":"10.1016\/j.ymthe.2020.01.027_bib26","doi-asserted-by":"crossref","first-page":"17972","DOI":"10.1038\/s41598-017-18225-w","article-title":"miRNA-36 inhibits KSHV, EBV, HSV-2 infection of cells via stifling expression of interferon induced transmembrane protein 1 (IFITM1)","volume":"7","author":"Hussein","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ymthe.2020.01.027_bib27","doi-asserted-by":"crossref","first-page":"10221","DOI":"10.1128\/JVI.00882-12","article-title":"Hepatitis C virus infection modulates expression of interferon stimulatory gene IFITM1 by upregulating miR-130A","volume":"86","author":"Bhanja Chowdhury","year":"2012","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2020.01.027_bib28","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/hep.26066","article-title":"IFITM1 is a tight junction protein that inhibits hepatitis C virus entry","volume":"57","author":"Wilkins","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.ymthe.2020.01.027_bib29","doi-asserted-by":"crossref","first-page":"12881","DOI":"10.1128\/JVI.05633-11","article-title":"ISG56 and IFITM1 proteins inhibit hepatitis C virus replication","volume":"85","author":"Raychoudhuri","year":"2011","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2020.01.027_bib30","doi-asserted-by":"crossref","first-page":"25946","DOI":"10.1074\/jbc.M115.657346","article-title":"The interferon-induced transmembrane proteins, IFITM1, IFITM2, and IFITM3 inhibit hepatitis C virus entry","volume":"290","author":"Narayana","year":"2015","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ymthe.2020.01.027_bib31","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1128\/JVI.01531-10","article-title":"The IFITM proteins inhibit HIV-1 infection","volume":"85","author":"Lu","year":"2011","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2020.01.027_bib32","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.cell.2009.12.017","article-title":"The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus","volume":"139","author":"Brass","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2020.01.027_bib33","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1016\/j.celrep.2016.05.074","article-title":"The IFITMs inhibit Zika virus replication","volume":"15","author":"Savidis","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.ymthe.2020.01.027_bib34","doi-asserted-by":"crossref","first-page":"e02003-18","DOI":"10.1128\/JVI.02003-18","article-title":"Interferon-induced transmembrane protein 1 restricts replication of viruses that enter cells via the plasma membrane","volume":"93","author":"Smith","year":"2019","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2020.01.027_bib35","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1099\/vir.0.066555-0","article-title":"Human respiratory syncytial virus infection is inhibited by IFN-induced transmembrane proteins","volume":"96","author":"Zhang","year":"2015","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.ymthe.2020.01.027_bib36","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1128\/JVI.02924-14","article-title":"Live-attenuated measles virus vaccine targets dendritic cells and macrophages in muscle of nonhuman primates","volume":"89","author":"Rennick","year":"2015","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2020.01.027_bib37","doi-asserted-by":"crossref","first-page":"4714","DOI":"10.1128\/JVI.02633-09","article-title":"In\u00a0vivo tropism of attenuated and pathogenic measles virus expressing green fluorescent protein in macaques","volume":"84","author":"de Vries","year":"2010","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.ymthe.2020.01.027_bib38","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.virol.2006.09.049","article-title":"Tyrosine 110 in the measles virus phosphoprotein is required to block STAT1 phosphorylation","volume":"360","author":"Devaux","year":"2007","journal-title":"Virology"},{"key":"10.1016\/j.ymthe.2020.01.027_bib39","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/BF01863914","article-title":"Beitrag zur kollektiven Behandlung pharmakologischer Reihenversuche","volume":"162","author":"K\u00e4rber","year":"1931","journal-title":"Naunyn Schmiedebergs Arch. Exp. Pathol. Pharmakol."},{"key":"10.1016\/j.ymthe.2020.01.027_bib40","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.ymthe.2020.01.027_bib41","doi-asserted-by":"crossref","first-page":"R106","DOI":"10.1186\/gb-2010-11-10-r106","article-title":"Differential expression analysis for sequence count data","volume":"11","author":"Anders","year":"2010","journal-title":"Genome Biol."},{"key":"10.1016\/j.ymthe.2020.01.027_bib42","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s12859-017-1559-2","article-title":"Reactome pathway analysis: a high-performance in-memory approach","volume":"18","author":"Fabregat","year":"2017","journal-title":"BMC Bioinformatics"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001620300861?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001620300861?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:56:54Z","timestamp":1761501414000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001620300861"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S1525001620300861"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2020.01.027","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Type 1 Interferon Responses Underlie Tumor-Selective Replication of Oncolytic Measles Virus","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2020.01.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}]}}